Immunotherapeutic Strategies for the Treatment of Glioma

Immunotherapeutic Strategies for the Treatment of Glioma provides an overview of the current state of immunotherapy for primary brain tumors, including peptide, dendritic cell, heat shock protein vaccines, immune checkpoint blockade, myeloid cells, oncolytic viruses, and CAR T cell therapy. It is a valuable resource for cancer researchers, oncologists, and biomedical field members interested in novel strategies to fight glioblastoma.

\n Format: Hardback
\n Length: 190 pages
\n Publication date: 14 September 2021
\n Publisher: Elsevier Science Publishing Co Inc
\n

Immunotherapeutic Strategies for the Treatment of Glioma: A Comprehensive Review

Primary brain tumors, particularly gliomas, continue to pose significant challenges in cancer treatment. The recent failure of large clinical trials has heightened the interest in immunotherapeutic approaches as potential alternatives. Immunotherapeutic Strategies for the Treatment of Glioma provides a comprehensive review of the current state of immunotherapy for glioma.

This book is of immense interest to patients, clinicians, and researchers alike, as it offers insights into the most promising approaches in the field. It serves as a foundation for considering novel and combination therapies that can improve the outcomes for patients with this devastating disease.

The book discusses various types of immunotherapies for glioma, including peptide, dendritic cell, and heat shock protein vaccines. It also explores immune checkpoint blockade, myeloid cells as targets, oncolytic viruses, and CAR T cell therapy. Furthermore, it delves into the mechanisms of immune suppression in patients and the role of immunogenomics in personalized treatment.

This volume is a valuable resource for cancer researchers, oncologists, and numerous members of the biomedical field who are actively engaged in exploring novel strategies to combat glioblastoma. It provides a comprehensive understanding of the immune landscape and offers insights into the potential of immunotherapies in improving patient outcomes.

While immunotherapies have shown promising results in treating glioma, there are still challenges to be addressed. Further research is needed to improve the efficacy and safety of these therapies, as well as to identify novel targets and combination therapies.

In conclusion, Immunotherapeutic Strategies for the Treatment of Glioma is a comprehensive and timely review of the current state of immunotherapy for glioma. It provides valuable insights into the most promising approaches in the field and serves as a foundation for future research and clinical development. By leveraging the immune system's potential to fight cancer, we can hope to improve the outcomes for patients with glioma and other brain tumors.

\n Weight: 554g\n
Dimension: 199 x 242 x 16 (mm)\n
ISBN-13: 9780128197554\n \n